| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | H3598Y1TLJ |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 3 | D008545 | ClinicalTrials |
| Kidney Neoplasms | 3 | D007680 | ClinicalTrials |
| Carcinoma, Renal Cell | 3 | D002292 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Gliosarcoma | 2 | D018316 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Brain Neoplasms | 2 | D001932 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Ependymoma | 1 | D004806 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Astrocytoma | 1 | D001254 | ClinicalTrials |
| Ependymoma | 1 | D004806 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108060 |
| FDA SRS | H3598Y1TLJ |
CONTENTS